» Articles » PMID: 1759558

Neuropathological Stageing of Alzheimer-related Changes

Overview
Specialty Neurology
Date 1991 Jan 1
PMID 1759558
Citations 6281
Authors
Affiliations
Soon will be listed here.
Abstract

Eighty-three brains obtained at autopsy from nondemented and demented individuals were examined for extracellular amyloid deposits and intraneuronal neurofibrillary changes. The distribution pattern and packing density of amyloid deposits turned out to be of limited significance for differentiation of neuropathological stages. Neurofibrillary changes occurred in the form of neuritic plaques, neurofibrillary tangles and neuropil threads. The distribution of neuritic plaques varied widely not only within architectonic units but also from one individual to another. Neurofibrillary tangles and neuropil threads, in contrast, exhibited a characteristic distribution pattern permitting the differentiation of six stages. The first two stages were characterized by an either mild or severe alteration of the transentorhinal layer Pre-alpha (transentorhinal stages I-II). The two forms of limbic stages (stages III-IV) were marked by a conspicuous affection of layer Pre-alpha in both transentorhinal region and proper entorhinal cortex. In addition, there was mild involvement of the first Ammon's horn sector. The hallmark of the two isocortical stages (stages V-VI) was the destruction of virtually all isocortical association areas. The investigation showed that recognition of the six stages required qualitative evaluation of only a few key preparations.

Citing Articles

Alzheimer's disease neuropathology and its estimation with fluid and imaging biomarkers.

Thal D, Poesen K, Vandenberghe R, De Meyer S Mol Neurodegener. 2025; 20(1):33.

PMID: 40087672 DOI: 10.1186/s13024-025-00819-y.


Probe-dependent Proximity Profiling (ProPPr) Uncovers Similarities and Differences in Phospho-Tau-Associated Proteomes Between Tauopathies.

Morderer D, Wren M, Liu F, Kouri N, Maistrenko A, Khalil B Mol Neurodegener. 2025; 20(1):32.

PMID: 40082954 PMC: 11905455. DOI: 10.1186/s13024-025-00817-0.


Vulnerability of the entorhinal cortex II to neurodegeneration in Alzheimer's disease.

Reyes-Pablo A, Luna-Viramontes N, Montiel-Sosa J, Ontiveros-Torres M, Garces-Ramirez L, de la Cruz-Lopez F Brain Commun. 2025; 7(2):fcaf091.

PMID: 40078869 PMC: 11897590. DOI: 10.1093/braincomms/fcaf091.


Impact of amygdala functional connectivity on cognitive impairment in Alzheimer's disease.

Kicik A, Kurt E, Hari E, Ulasoglu-Yildiz C, Gurvit H, Demiralp T Neurol Sci. 2025; .

PMID: 40055296 DOI: 10.1007/s10072-025-08091-0.


Increased frontocortical microvascular raspberry density in frontotemporal lobar degeneration compared to Lewy body disease and control cases: a neuropathological study.

Olofsson H, Englund E Free Neuropathol. 2025; 6:7.

PMID: 40052111 PMC: 11884261. DOI: 10.17879/freeneuropathology-2025-6178.


References
1.
Braak H, Braak E . Alzheimer's disease: striatal amyloid deposits and neurofibrillary changes. J Neuropathol Exp Neurol. 1990; 49(3):215-24. View

2.
Tierney M, Fisher R, Lewis A, Zorzitto M, SNOW W, Reid D . The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease: a clinicopathologic study of 57 cases. Neurology. 1988; 38(3):359-64. DOI: 10.1212/wnl.38.3.359. View

3.
Hubbard B, FENTON G, Anderson J . A quantitative histological study of early clinical and preclinical Alzheimer's disease. Neuropathol Appl Neurobiol. 1990; 16(2):111-21. DOI: 10.1111/j.1365-2990.1990.tb00940.x. View

4.
Khachaturian Z . Diagnosis of Alzheimer's disease. Arch Neurol. 1985; 42(11):1097-105. DOI: 10.1001/archneur.1985.04060100083029. View

5.
Castano E, Frangione B . Human amyloidosis, Alzheimer disease and related disorders. Lab Invest. 1988; 58(2):122-32. View